Key result
PWV/GLS ratio detects altered ventricular-arterial coupling in hypertension with ~0.84 AUROC accuracy.
Why the study?
The benefit of the PWV/GLS ratio as a marker of ventricular-arterial coupling in hypertensive patients compared to healthy controls was not established.
Observational (n=135)
Answers are grounded in this paper and cite their sources.
PWV/GLS ratio may refine VAC assessment in hypertension; leaves open clinical utility and outcome impact.
OBJECTIVE: The physiological interaction between the left ventricle (LV) and the arterial system, defined as ventricular-arterial coupling (VAC), facilitates the optimal volume of cardiac work and cardiovascular performance. The aim of this study was to evaluate the benefit of PWV/GLS ratio associated with other vascular and cardiac performance parameters in hypertensive patients compared to age-matched healthy controls. PATIENTS AND METHODS: We calculated the ratio of pulse wave velocity (PWV), as a marker of arterial stiffness, to global longitudinal strain (GLS), as a marker of left ventricular function in 135 patients divided in 3 groups, as follows: group 1 (HT + CAD) enrolled 54 hypertensive patients with coronary artery disease, group 2 (HT) enrolled 43 hypertensive patients and group 3 (CON) represented the control group consisting of 38 age-matched healthy subjects. RESULTS: GLS values were significantly reduced in HT+CAD (-17.50±7.2) vs. HT (-17.95±5.3) vs. control (-20.13±4.6) (p-value <0.001). PWV values were higher in HT+CAD (9.90±3.1) and HT (9.70±2.5) vs. control (7.85±3.2) (p-value <0.001). VA coupling measured by the PWV/GLS ratio showed significantly lower values in HT+CAD and HT vs. control (p-value <0.001). The ROC curve identified a threshold of -0.054 of the PWV/GLS ratio to detect altered ventricular-arterial coupling AUROC = 0.836, 95% CI [0.762; 0.909]. CONCLUSIONS: This study demonstrated that assessment of the PWV/GLS ratio represents a useful tool to detect altered ventricular-arterial coupling in hypertensive patients. The perspectives of future use could include monitoring of earlier development of multiple organ damage in hypertensive patients and the efficacy of the different hypertensive medications. Extensive prospective studies are needed to confirm this hypothesis.
No takes yet. Share an insight, caveat, or question.
Stoichescu-Hogea et al. (2022) conducted an observational in Hypertension with or without coronary artery disease (n=135). Hypertension with or without coronary artery disease vs. Age-matched healthy controls was evaluated on Altered ventricular-arterial coupling (assessed via AUROC for PWV/GLS ratio threshold) (AUROC 0.836, 95% CI 0.762-0.909). A PWV/GLS ratio threshold of -0.054 detected altered ventricular-arterial coupling in hypertensive patients with high accuracy (AUROC 0.836; 95% CI 0.762-0.909).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: